Factor | All patients N=51 | Discharged alive N=40 | Died in-hospital N=11 | Univariate analysis p value* |
---|---|---|---|---|
Age ≥53 years, n (%) | 24 (47.1) | 16 (40.0) | 8 (72.7) | 0.05 |
Male, n (%) | 31 (60.8) | 26 (65.0) | 5 (45.5) | 0.24 |
Oceanic†, n (%) | 43 (84.3) | 34 (85.0) | 9 (81.8) | 0.80 |
Charlson's score >3, n (%) | 20 (39.2) | 13 (32.5) | 7 (63.4) | 0.08 |
Chronic renal replacement therapy, n (%) | 3 (5.9) | 2 (5.0) | 1 (9.1) | 0.61 |
Left-sided IE, n (%) | 47 (92.2) | 37 (92.5) | 10 (90.9) | 0.86 |
Native valve IE, n (%) | 34 (66.7) | 27 (67.5) | 7 (63.6) | 0.81 |
Aetiology of valve disease, n (%) | 0.17 | |||
Rheumatic heart disease | 19 (37.2) | 17 (42.5) | 2 (18.2) | |
Degenerative | 12 (23.5) | 7 (17.5) | 5 (45.5) | |
Congenital | 6 (11.8) | 5 (12.5) | 1 (9.1) | |
Functional | 2 (3.9) | 2 (5.0) | 0 | |
Healthcare-related IE, n (%) | 8 (15.7) | 6 (15.0) | 2 (18.2) | 0.80 |
Microbiology, n (%) | ||||
Streptococcus spp | 15 (29.4) | 12 (30.0) | 3 (27.3) | 0.86 |
Staphylococcus aureus | 16 (31.4) | 12 (30.0) | 4 (36.4) | 0.69 |
Acute heart failure, n (%) | 17 (33.3) | 13 (32.5) | 4 (36.4) | 0.81 |
Severe valve regurgitation, n (%) | 15 (29.4) | 13 (32.5) | 2 (18.2) | 0.33 |
Neurological complication, n (%) | 23 (45.1) | 18 (45.0) | 5 (45.5) | 0.87 |
Shock, n (%) | 7 (13.7) | 2 (5.0) | 5 (45.5) | <0.01 |
Vegetation length ≥15 mm, n (%) | 10 (19.6) | 7 (17.5) | 3 (27.3) | 0.39 |
Perivalvular abscess‡, n (%) | 5 (9.8) | 4 (10.0) | 1 (9.1) | 0.94 |
Cardiac surgery, n (%) | 22 (43.1) | 20 (50.0) | 2 (18.2) | 0.06 |
Cardiac surgery denied§, n (%) | 19 (37.3) | 12 (30.0) | 7 (63.8) | 0.04 |
*Comparison of patients discharged alive versus patients who died during their first hospital admission.
†Includes indigenous Melanesians and Polynesians.
‡On echocardiography.
§In spite of at least one indication according to guidelines at the time of treatment.
IE, infective endocarditis.